Ashley M. Holder

3.2k total citations · 1 hit paper
24 papers, 1.0k citations indexed

About

Ashley M. Holder is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Ashley M. Holder has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Surgery. Recurrent topics in Ashley M. Holder's work include Congenital Diaphragmatic Hernia Studies (4 papers), Congenital heart defects research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ashley M. Holder is often cited by papers focused on Congenital Diaphragmatic Hernia Studies (4 papers), Congenital heart defects research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ashley M. Holder collaborates with scholars based in United States, Netherlands and Australia. Ashley M. Holder's co-authors include Argun Akçakanat, Funda Meric‐Bernstam, Daryl A. Scott, Annelies de Klein, Dick Tibboel, Merel Klaassens, B. Lee, Margaret Wat, Genevieve M. Boland and Kailan Sierra-Davidson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature reviews. Cancer and Cancer Research.

In The Last Decade

Ashley M. Holder

21 papers receiving 992 citations

Hit Papers

Defining clinically useful biomarkers of immune checkpoin... 2024 2026 2025 2024 25 50 75 100

Peers

Ashley M. Holder
Sang Hoon Shin South Korea
Chang-Goo Huh United States
Cuiqi Zhou United States
Tammy Sadler United States
Julian A. Gingold United States
Jin Cen China
Jin‐Sook Jeong South Korea
Sang Hoon Shin South Korea
Ashley M. Holder
Citations per year, relative to Ashley M. Holder Ashley M. Holder (= 1×) peers Sang Hoon Shin

Countries citing papers authored by Ashley M. Holder

Since Specialization
Citations

This map shows the geographic impact of Ashley M. Holder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley M. Holder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley M. Holder more than expected).

Fields of papers citing papers by Ashley M. Holder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley M. Holder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley M. Holder. The network helps show where Ashley M. Holder may publish in the future.

Co-authorship network of co-authors of Ashley M. Holder

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley M. Holder. A scholar is included among the top collaborators of Ashley M. Holder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley M. Holder. Ashley M. Holder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holder, Ashley M., Aikaterini Dedeilia, Kailan Sierra-Davidson, et al.. (2024). Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours. Nature reviews. Cancer. 24(7). 498–512. 112 indexed citations breakdown →
2.
Holder, Ashley M., et al.. (2024). Interdisciplinary Implementation of a Synoptic Reporting Template for Melanoma Nodal Surveillance Ultrasound. Annals of Surgical Oncology. 31(12). 8222–8229.
3.
Rattani, Abbas, Jeremy Gaskins, Grant McKenzie, et al.. (2022). Racial Differences in Population Demographics, Tumor Characteristics, and Overall Survival in Merkel Cell Carcinoma Patients. Journal of Investigative Dermatology. 142(10). 2840–2840. 1 indexed citations
4.
Court, Karem A., et al.. (2021). Gold Nanorod Hydrogel Film for Laser‐Induced Hyperthermic Intraperitoneal Chemotherapy to Treat Peritoneal Malignancies. SHILAP Revista de lepidopterología. 1(10). 4 indexed citations
5.
Rose, J. Bart, et al.. (2021). Ranking NIH Funding of Surgical Departments Based Upon a Modified Index. Journal of Surgical Research. 270. 335–340.
6.
Holder, Ashley M. & Artūras Žiemys. (2020). Lymphatic Transport Efficiency Determines Metastatic Potential of Cutaneous Melanoma. Frontiers in Oncology. 10. 1607–1607. 2 indexed citations
7.
Suresh, Rishi, Artūras Žiemys, & Ashley M. Holder. (2020). Dissecting the Lymphatic System to Predict Melanoma Metastasis. Frontiers in Oncology. 10. 576190–576190. 5 indexed citations
8.
Žiemys, Artūras, Michelle Kim, Alexander M. Menzies, et al.. (2020). Integration of Digital Pathologic and Transcriptomic Analyses Connects Tumor-Infiltrating Lymphocyte Spatial Density With Clinical Response to BRAF Inhibitors. Frontiers in Oncology. 10. 757–757. 6 indexed citations
9.
Mu, Chaofeng, Xiaoyan Wu, Joy Wolfram, et al.. (2018). Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer. Clinical Cancer Research. 24(19). 4900–4912. 27 indexed citations
10.
Žiemys, Artūras, Katsuhiko Yokoi, Miloš Kojić, et al.. (2018). Progression-dependent transport heterogeneity of breast cancer liver metastases as a factor in therapeutic resistance. Journal of Controlled Release. 291. 99–105. 10 indexed citations
11.
Holder, Ashley M., Argun Akçakanat, Farrell Adkins, et al.. (2015). Epithelial to mesenchymal transition is associated with rapamycin resistance. Oncotarget. 6(23). 19500–19513. 22 indexed citations
12.
Akçakanat, Argun, et al.. (2013). Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway. Surgical Oncology Clinics of North America. 22(4). 641–664. 166 indexed citations
13.
Wat, Margaret, T. Beck, Andrés Hernández, et al.. (2012). Mouse model reveals the role of SOX7 in the development of congenital diaphragmatic hernia associated with recurrent deletions of 8p23.1. Human Molecular Genetics. 21(18). 4115–4125. 64 indexed citations
14.
Holder, Ashley M., Ana M. González-Angulo, Huiqin Chen, et al.. (2012). High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients. Breast Cancer Research and Treatment. 137(1). 319–327. 97 indexed citations
15.
Wat, Margaret, Danielle Veenma, Jacob S. Hogue, et al.. (2011). Genomic alterations that contribute to the development of isolated and non-isolated congenital diaphragmatic hernia. Journal of Medical Genetics. 48(5). 299–307. 65 indexed citations
16.
Wat, Margaret, Oleg A. Shchelochkov, Ashley M. Holder, et al.. (2009). Chromosome 8p23.1 deletions as a cause of complex congenital heart defects and diaphragmatic hernia. American Journal of Medical Genetics Part A. 149A(8). 1661–1677. 129 indexed citations
17.
Holder, Ashley M., Brett H. Graham, Brendan Lee, & Daryl A. Scott. (2007). Fine–Lubinsky syndrome: Sibling pair suggests possible autosomal recessive inheritance. American Journal of Medical Genetics Part A. 143A(21). 2576–2580. 3 indexed citations
18.
Scott, Daryl A., Merel Klaassens, Ashley M. Holder, et al.. (2007). Genome-wide oligonucleotide-based array comparative genome hybridization analysis of non-isolated congenital diaphragmatic hernia. Human Molecular Genetics. 16(4). 424–430. 67 indexed citations
19.
Holder, Ashley M., Merel Klaassens, Dick Tibboel, et al.. (2007). Genetic Factors in Congenital Diaphragmatic Hernia. The American Journal of Human Genetics. 80(5). 825–845. 161 indexed citations
20.
Hovsepian, David M., et al.. (2006). Comparison of Adjunctive Use of Rofecoxib versus Ibuprofen in the Management of Postoperative Pain after Uterine Artery Embolization. Journal of Vascular and Interventional Radiology. 17(4). 665–670. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026